DexCom Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Welcome to the Morgan Stanley Healthcare conference 2020 here as we progress through the morning. My name is David Lewis, medical device analyst at Morgan Stanley. It's my pleasure to have with us here this morning, as we continue through the morning, DexCom and multiple members of management. We have a full house here. We have Quentin Blackford, the CFO and COO; Jereme Sylvain, SVP of Finance and Chief Accounting Officer; and Steve Pacelli, who just recently jumped in here last minute and is also going to help us out this morning.
So with that, I want to jump straight into questions. We're not going to do our traditional preamble here.
Questions & Answers
Quentin, I wanted to start off very top line and we'll kind of jump into your core recovery in a bit. But look, we saw in the second quarter a 25% increase in sequential volumes in the business, despite kind of COVID-19. And I think we all know that TAM expanding drivers and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |